Sanofi Starts Building New Insulin Manufacturing Plant in Germany

MT Newswires · 3d ago
07:25 AM EDT, 10/19/2026 (MT Newswires) -- French pharmaceutical company Sanofi (SAN.PA) broke ground on a new, 36,000-square-meter insulin production facility at its BioCampus research and manufacturing site in Frankfurt, Germany. The Frankfurt BioCampus covers the entire insulin manufacturing value chain, according to a Monday release. Full production of insulin active pharmaceutical ingredients from the facility is scheduled for 2032.